Diversified Trust’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,795
| Closed | -$118K | – | 946 |
|
|
2025
Q1 | $118K | Hold |
15,795
| – | – | ﹤0.01% | 884 |
|
|
2024
Q4 | $119K | Sell |
15,795
-5,885
| -27% | -$44.3K | ﹤0.01% | 877 |
|
|
2024
Q3 | $165K | Sell |
21,680
-3,072
| -12% | -$23.3K | ﹤0.01% | 845 |
|
|
2024
Q2 | $153K | Buy |
24,752
+3,774
| +18% | +$23.3K | ﹤0.01% | 803 |
|
|
2024
Q1 | $107K | Hold |
20,978
| – | – | ﹤0.01% | 790 |
|
|
2023
Q4 | $126K | Hold |
20,978
| – | – | ﹤0.01% | 823 |
|
|
2023
Q3 | $149K | Buy |
20,978
+2,004
| +11% | +$14.2K | 0.01% | 764 |
|
|
2023
Q2 | $134K | Hold |
18,974
| – | – | ﹤0.01% | 785 |
|
|
2023
Q1 | $158K | Sell |
18,974
-263
| -1% | -$2.19K | 0.01% | 768 |
|
|
2022
Q4 | $221K | Sell |
19,237
-278
| -1% | -$3.19K | 0.01% | 701 |
|
|
2022
Q3 | $246K | Buy |
19,515
+107
| +0.6% | +$1.35K | 0.01% | 613 |
|
|
2022
Q2 | $205K | Buy |
19,408
+1,200
| +7% | +$12.7K | 0.01% | 680 |
|
|
2022
Q1 | $296K | Hold |
18,208
| – | – | 0.01% | 623 |
|
|
2021
Q4 | $252K | Buy |
+18,208
| New | +$252K | 0.01% | 694 |
|